Literature DB >> 3593528

Acuity card testing of retarded children.

B G Hertz.   

Abstract

Evaluating the vision of retarded children is important, but it is often very difficult because the children cannot cooperate with the usual symbol recognition acuity tests. A total of 33 unselected children with Down's syndrome were tested with a standard symbol recognition test (Osterberg) and with a new test using acuity cards, which contain black and white square-wave gratings. The acuity cards were found to be useful for testing this group, both in terms of the children's ability to cooperate with the test and the test-retest variability of the results. Although eyes with strabismic amblyopia showed better acuity for gratings than for symbols, there was general agreement with symbol recognition acuities of the same patients. Acuity cards were also used to test 19 severely retarded young children with cerebral palsy, who were unable to be tested with symbols. Acuity card tests were almost always possible with this group, too, though test-retest variability was greater for these children. Acuity card testing can provide useful information about the visual acuity of many retarded children in less than 10 minutes.

Entities:  

Mesh:

Year:  1987        PMID: 3593528     DOI: 10.1016/0166-4328(87)90246-4

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  3 in total

Review 1.  Assessment of visual acuity in multiply handicapped children.

Authors:  R T Mackie; D L McCulloch
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

2.  Clinical Utility of 'Peekaboo Vision' Application for Measuring Grating Acuity in Children with Down Syndrome.

Authors:  Rebecca Sumalini; PremNandhini Satgunam; Ahalya Subramanian; Miriam Conway
Journal:  Br Ir Orthopt J       Date:  2022-05-04

3.  Cytogenetic findings indicate heterogeneity in patients with blepharophimosis, epicanthus inversus, and developmental delay.

Authors:  M Warburg; M Bugge; K Brøndum-Nielsen
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.